Versha Banerji, MD, FRCPC - The Ties That Bind: Exploring the Role of Noncovalent BTK Inhibitors in CLL Treatment

Visit https://www.peervoice.com/WJH860 to view the entire programme with slides. After completing “Versha Banerji, MD, FRCPC - The Ties That Bind: Exploring the Role of Noncovalent BTK Inhibitors in CLL Treatment”, participants will be able to: Explain differences in mechanism of action between covalent BTK inhibitors and noncovalent BTK inhibitors; Discuss the clinical evidence for noncovalent BTK inhibitors; and Outline evidence-based strategies to integrate noncovalent BTK inhibitors into treatment paradigms for patients with chronic lymphocytic leukemia.

Listen